Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 109901-109950 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03282656
Gene Transfer for Sickle Cell Disease
PHASE1
Active, not recruiting
10 participants
Started: Feb 13, 2018 · Completed: Dec 13, 2024
1 condition
1 sponsor
2 locations
NCT03445936
PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure
NA
Active, not recruiting
100 participants
Started: Feb 13, 2018 · Completed: Oct 31, 2027
1 condition
1 sponsor
4 locations
NCT03327532
Acute Heart Failure - COngestion Repeated Evaluation (AHF-CORE)
NA
Recruiting
80 participants
Started: Feb 13, 2018 · Completed: Feb 28, 2026
1 condition
1 sponsor
2 locations
NCT03217786
Early Post Transplant Cardiac Allograft Vasculopathy
N/A
Active, not recruiting
80 participants
Started: Feb 12, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03413800
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant
PHASE2
Active, not recruiting
10 participants
Started: Feb 12, 2018 · Completed: Jan 1, 2026
2 conditions
3 sponsors
1 location
NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
PHASE2
Active, not recruiting
47 participants
Started: Feb 12, 2018 · Completed: Apr 12, 2026
4 conditions
3 sponsors
1 location
NCT03649698
Exercise and Nutrition for Healthy AgeiNg
NA
Recruiting
180 participants
Started: Feb 12, 2018 · Completed: Jun 30, 2025
1 condition
4 sponsors
1 location
NCT03851523
Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.
N/A
Recruiting
400 participants
Started: Feb 12, 2018 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT03400332
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
PHASE1/PHASE2
Active, not recruiting
281 participants
Started: Feb 12, 2018 · Completed: Nov 30, 2025
2 conditions
1 sponsor
72 locations
NCT03406247
Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma
PHASE2
Recruiting
140 participants
Started: Feb 12, 2018 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT03437681
Tissue-specific Effects of Insufficient Sleep
NA
Active, not recruiting
18 participants
Started: Feb 12, 2018 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT03225547
Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer
PHASE2
Active, not recruiting
74 participants
Started: Feb 12, 2018 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT03441165
Intraoperative Laxity Assessment of ACL Reconstruction, ACL Revision and MAT
N/A
Recruiting
1,500 participants
Started: Feb 10, 2018 · Completed: Jun 30, 2032
1 condition
1 sponsor
1 location
NCT03404258
ET1 Concentration, Metabolic Pathway Activation, and Pulmonary Blood Flow in Infants Undergoing Superior Cavo-Pulmonary Anastomosis
N/A
Recruiting
50 participants
Started: Feb 10, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04481087
Clinical Comparison of Different Adhesives in NCCLs
NA
Active, not recruiting
34 participants
Started: Feb 10, 2018 · Completed: Jun 10, 2026
1 condition
1 sponsor
1 location
NCT03717844
Registry for Adults With Plasma Cell Disorders (PCD's)
N/A
Recruiting
2,000 participants
Started: Feb 9, 2018 · Completed: Feb 28, 2029
9 conditions
1 sponsor
1 location
NCT03049254
Mayo AVC Registry and Biobank
N/A
Recruiting
1,000 participants
Started: Feb 9, 2018 · Completed: Mar 31, 2026
17 conditions
2 sponsors
2 locations
NCT03319485
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease
NA
Active, not recruiting
92 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2025
1 condition
1 sponsor
20 locations
NCT03083184
"Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients"
PHASE3
Recruiting
400 participants
Started: Feb 9, 2018 · Completed: Dec 31, 2027
1 condition
14 sponsors
1 location
NCT03223610
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
PHASE1/PHASE2
Recruiting
145 participants
Started: Feb 9, 2018 · Completed: Dec 1, 2026
4 conditions
1 sponsor
1 location
NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
PHASE3
Active, not recruiting
180 participants
Started: Feb 9, 2018 · Completed: Sep 30, 2025
1 condition
3 sponsors
23 locations
NCT03301441
Sensitivity to Acute Cerebral Ischemia in Migrainers
N/A
Active, not recruiting
605 participants
Started: Feb 9, 2018 · Completed: Jul 31, 2024
3 conditions
1 sponsor
1 location
NCT04266041
High-density EEG in Neurological Disorders
NA
Enrolling by invitation
100 participants
Started: Feb 9, 2018 · Completed: Mar 9, 2028
3 conditions
1 sponsor
1 location
NCT03410875
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
PHASE2
Active, not recruiting
30 participants
Started: Feb 9, 2018 · Completed: Jan 31, 2026
3 conditions
3 sponsors
9 locations
NCT03479580
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
N/A
Recruiting
1,600 participants
Started: Feb 8, 2018 · Completed: Feb 29, 2028
4 conditions
5 sponsors
1 location
NCT03445637
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®
N/A
Recruiting
540 participants
Started: Feb 8, 2018 · Completed: Jul 5, 2025
1 condition
1 sponsor
1 location
NCT03147612
Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
22 participants
Started: Feb 8, 2018 · Completed: Feb 28, 2027
6 conditions
1 sponsor
1 location
NCT03312400
Low-Dose Danazol for the Treatment of Telomere Related Diseases
PHASE2
Recruiting
40 participants
Started: Feb 8, 2018 · Completed: Oct 29, 2027
1 condition
1 sponsor
1 location
NCT03041688
Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
PHASE1
Active, not recruiting
58 participants
Started: Feb 8, 2018 · Completed: Jun 30, 2026
4 conditions
1 sponsor
13 locations
NCT03872921
norUrsodeoxycholic Acid vs Placebo in PSC
PHASE3
Active, not recruiting
303 participants
Started: Feb 8, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT03257761
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
PHASE1
Active, not recruiting
55 participants
Started: Feb 7, 2018 · Completed: Dec 31, 2025
28 conditions
3 sponsors
3 locations
NCT03456674
LaseMD System for the Treatment of Melasma
NA
Active, not recruiting
10 participants
Started: Feb 7, 2018 · Completed: Jun 30, 2019
1 condition
1 sponsor
1 location
NCT03569826
Canadian Network for Autoimmune Liver Disease
N/A
Recruiting
2,500 participants
Started: Feb 7, 2018 · Completed: Dec 31, 2028
3 conditions
1 sponsor
15 locations
NCT03311308
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
PHASE1
Recruiting
30 participants
Started: Feb 7, 2018 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT03283917
Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
PHASE1
Active, not recruiting
21 participants
Started: Feb 7, 2018 · Completed: May 18, 2027
3 conditions
3 sponsors
1 location
NCT03384238
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
PHASE1/PHASE2
Recruiting
27 participants
Started: Feb 7, 2018 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT03470480
rTMS for Craving in Methamphetamine Use Disorder
NA
Recruiting
50 participants
Started: Feb 7, 2018 · Completed: Sep 1, 2025
6 conditions
1 sponsor
1 location
NCT03369106
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
N/A
Active, not recruiting
120 participants
Started: Feb 6, 2018 · Completed: Feb 5, 2026
1 condition
1 sponsor
1 location
NCT03374085
A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
PHASE1/PHASE2
Active, not recruiting
201 participants
Started: Feb 6, 2018 · Completed: Jan 31, 2028
1 condition
1 sponsor
54 locations
NCT03287271
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
PHASE1/PHASE2
Recruiting
90 participants
Started: Feb 6, 2018 · Completed: Apr 30, 2026
1 condition
3 sponsors
1 location
NCT03430037
Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women
PHASE2
Enrolling by invitation
40 participants
Started: Feb 6, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03061539
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature
PHASE2
Active, not recruiting
380 participants
Started: Feb 6, 2018 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT03619356
Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy
N/A
Enrolling by invitation
100 participants
Started: Feb 5, 2018 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT03481283
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
N/A
Recruiting
40 participants
Started: Feb 5, 2018 · Completed: Jan 31, 2029
2 conditions
1 sponsor
2 locations
NCT03353584
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
NA
Recruiting
76 participants
Started: Feb 5, 2018 · Completed: Nov 30, 2026
2 conditions
1 sponsor
2 locations
NCT03236987
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
PHASE3
Recruiting
424 participants
Started: Feb 5, 2018 · Completed: Feb 5, 2029
2 conditions
1 sponsor
3 locations
NCT03458429
Safety, Efficacy of FFP From Healthy Donors to Ameliorate Frailty and Enhance Immune Function in Older Individuals
PHASE1/PHASE2
Enrolling by invitation
30 participants
Started: Feb 5, 2018 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT03225664
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Feb 3, 2018 · Completed: Dec 31, 2025
10 conditions
2 sponsors
2 locations
NCT07044791
Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NA
Active, not recruiting
120 participants
Started: Feb 2, 2018 · Completed: Feb 2, 2026
2 conditions
1 sponsor
1 location
NCT03462888
Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients
N/A
Active, not recruiting
113 participants
Started: Feb 2, 2018 · Completed: Dec 31, 2024
1 condition
5 sponsors
20 locations
Previous
1
More pages
2196
2197
2198
2199
2200
2201
2202
More pages
2369
Next